Canadian licensed producer of GMP-grade psilocybin Optimi Health Corp. (OTCQX:OPTHF) closed a non-brokered private placement of 5,692,308 Optimi units at $0.236 each, for gross proceeds of $1.346.245 with Wilson Capital, the private equity division at Chip Wilson’s family office, and potential total proceeds of $2.379.579.
The new funds will be directed to supporting Optimi’s psychedelic product commercialization efforts, ongoing projects of psilocybin and MDMA research and clinical trials, in-house drug development, and general working capital.
